Target intelligence / Profile preview

RNA polymerase I transcription complex (Pol I transcription complex)

Target
Pol I transcription complex
Molecular classification
Enzyme complex, Transcription factor complex, Nucleolar protein complex
01

Overview

The RNA polymerase I (Pol I) transcription complex is a specialized multi-subunit assembly located within the nucleolus that is responsible for transcribing ribosomal DNA (rDNA) into the 45S precursor ribosomal RNA (rRNA). This process is the rate-limiting step in ribosome biogenesis, which is essential for protein synthesis and cellular growth (Ruggero & Pandolfi, 2003). The complex is recruited to the GC-rich promoter regions of rDNA by key transcription factors, including the Upstream Binding Factor (UBF) and Selectivity Factor 1 (SL1) (Drygin et al., 2011). In many cancers, Pol I transcription is significantly upregulated to meet the high metabolic demands of rapidly proliferating cells, making it a distinct therapeutic vulnerability (Bywater et al., 2012). Drugs targeting this complex, such as CX-5461, often exploit the high GC content of rDNA by stabilizing G-quadruplex structures, thereby blocking Pol I progression and triggering a nucleolar stress response (Xu et al., 2017). This disruption leads to the activation of p53-dependent and independent apoptotic pathways, providing a selective mechanism to eliminate cancer cells while potentially sparing normal cells with lower ribosome synthesis requirements (Peltonen et al., 2014; Quin et al., 2014).

Other names
GC-rich ribosomal DNA transcription complexrDNA transcription machineryRNA polymerase I pre-initiation complexNucleolar transcription complex
02

Mechanism of action

Inhibition of RNA polymerase I-mediated transcription of ribosomal DNA, often through stabilization of G-quadruplexes in GC-rich rDNA sequences or direct disruption of the Pol I complex assembly and elongation.

03

Biological functions

Ribosome biogenesisRibosomal RNA synthesisCell growth regulationNucleolar stress responseCell cycle progression
04

Disease associations

CancerHematologic malignancySolid tumorRibosomopathy
05

Safety considerations

MyelosuppressionNeutropeniaThrombocytopeniaPhotosensitivityPotential for off-target DNA damage response
06

Interacting drugs

CX-5461 (Pidnarulex)

3 more in the full profile.

07

Biomarkers

45S pre-rRNA levelsNucleophosmin (NPM1) nucleolar localizationp53 activation statusNucleolar size and morphologyUBF expression levels

Beyond the preview

Go deeper on RNA polymerase I transcription complex (Pol I transcription complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA polymerase I transcription complex (Pol I transcription complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call